I work as a researcher at the Faculty of Medicine studying protein-protein complexes arising at the host-pathogen interface, with the aim of understanding how pathogens evade the human immune defence. The main methods we are using are quantitative and structural mass spectrometry (cross-linking and hydrogen-deuterium exchange) in combination with single-particle cryo-EM. Since its start in 2018, I have been coordinating the Lund University Block Allocation Group (BAG) allocation to the SciLifeLab cryo-EM platforms in Stockholm and Umeå. 

Derek Logan's research group is based at the Dept. of Biochemistry and Structural Biology at Lund University. His research focuses on the elucidation of structure-function relationships in proteins and their complexes. A particular focus is on allosteric regulation of the essential enzyme ribonucleotide reductase and drug design against the medically important galectin family of proteins. The principal methods used in the Logan group are X-ray and neutron crystallography, small-angle X-ray scattering and cryo-electron microscopy. Dr. Logan worked for 15 years as a part-time beamline scientist at the MAX-lab synchrotron and is also responsible for the macromolecular crystallisation facility at Lund Protein Production Facility. He is Chief Scientific Officer of the company SARomics Biostructures AB at Medicon Village.